[Retracted] miRNA‑490‑3p promotes the metastatic progression of invasive ductal carcinoma

Ning Lu1, Mei Zhang2, Lu Lu3

  • 1Department of Breast Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin 300060, P.R. China.

Oncology Reports
|September 2, 2024
PubMed

Insights

This paper has been retracted due to concerns about duplicated data in western blotting, cell migration, invasion assays, and histology images. The findings were previously published elsewhere, leading to the retraction.

Area of Science:

  • Oncology Research
  • Biomedical Data Integrity

Context:

  • Concerns raised by a reader regarding data duplication.
  • Similar data appeared in previously published or submitted articles by different authors.
  • The journal submission date was prior to the other publications.

Purpose:

  • To address allegations of data duplication and plagiarism.
  • To maintain scientific integrity and ethical publishing standards.

Summary:

  • Western blotting, cell migration, invasion assay, and H&E-stained images showed striking similarities to previously published data.
  • The data in question was submitted or published elsewhere before the current paper's submission.
  • Retraction was decided due to the compromised integrity of the published findings.

Impact:

  • Retraction of the paper to uphold scientific accuracy.
  • Apology issued to the readership for the inconvenience caused by the duplicated data.
  • Reinforces the importance of original research and data verification in scientific publications.